ClinConnect ClinConnect Logo
Search / Trial NCT07149883

Evaluation of Mean Platelet Volume and Systemic Inflammatory Response Index (SIRI) in Patients of Acute Coronary Syndrome

Launched by ASSIUT UNIVERSITY ·

Trial Information

Current as of September 29, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at two blood markers called Mean Platelet Volume (MPV) and the Systemic Inflammatory Response Index (SIRI) to see how useful they are in diagnosing and predicting outcomes for people who have acute coronary syndrome—a condition that includes serious heart problems like heart attacks and unstable chest pain. The goal is to understand if these markers can help doctors better identify the severity of the condition and guide treatment decisions.

The study is open to adults of all genders, but there seems to be a wide and unusual age range listed, which might be a typo (typically, participants would be adults around 18 years and older). If you have recently experienced a heart event like a heart attack or unstable angina, you might be eligible to take part. Participants will likely have blood tests to measure MPV and SIRI, which involves simple blood draws. This study is not yet recruiting, so it’s important to check back later or talk to your doctor if you’re interested. Understanding these markers could help improve care for people with heart problems in the future.

Gender

ALL

Eligibility criteria

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Trial Officials

Ghada Hassan, Professor

Study Director

Assuit university hospital

Hanan Sharaf, Professor

Study Director

Assuit university hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported